Detalhe da pesquisa
1.
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.
Blood
; 143(2): 118-123, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647647
2.
Practice guideline: Preparation for CAR T-cell therapy in children and young adults with B-acute lymphoblastic leukaemia.
Br J Haematol
; 204(5): 1687-1696, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488312
3.
Immunotherapy with CD25/CD71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trial.
Cytotherapy
; 25(1): 82-93, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220712
4.
Clinically Applicable Assessment of Tisagenlecleucel CAR T Cell Treatment by Digital Droplet PCR for Copy Number Variant Assessment.
Int J Mol Sci
; 23(14)2022 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35886920
5.
Clinical Utility of Radiologic Disease Reassessment in the Management of Pediatric B-Cell Non-Hodgkin Lymphoma.
J Pediatr Hematol Oncol
; 43(3): e380-e384, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32218099
6.
CAR-T cell therapy in paediatric acute lymphoblastic leukaemia - past, present and future.
Br J Haematol
; 191(4): 617-626, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190266
7.
Siglec-6 CAR T: magic bullet for a moving target.
Blood
; 138(19): 1786-1787, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762132
8.
What is the diagnostic yield of bone marrow aspiration to exclude leukaemia prior to systemic treatment in juvenile idiopathic arthritis?
Br J Haematol
; 199(3): 447-451, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35974444
9.
Blinatumomab for infant acute lymphoblastic leukemia.
Blood
; 135(17): 1501-1504, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043146
10.
OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence.
J Immunol
; 194(1): 125-133, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25404365
11.
CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor.
J Immunol
; 194(3): 1080-9, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25539815
12.
Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation.
Br J Haematol
; 195(5): 805-811, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322864
13.
The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults.
Br J Haematol
; 192(2): e42-e44, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216967
14.
Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy.
Haematologica
; 101(4): 482-90, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802053
15.
CD19 chimeric antigen receptor T cell therapy for haematological malignancies.
Br J Haematol
; 169(4): 463-78, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25753571
16.
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
Br J Haematol
; 190(5): e274-e276, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32652563
17.
INSPIRED Symposium Part 4A: Access to CAR T Cell Therapy in Unique Populations with B Cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 30(1): 56-70, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821078
18.
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Blood Cancer J
; 14(1): 66, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622139
19.
The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.
Br J Haematol
; 162(3): 400-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23713628
20.
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells.
Blood Adv
; 7(9): 1725-1738, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453632